These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 16356575)
1. Targeted drug delivery crossing cytoplasmic membranes of intended cells via ligand-grafted sterically stabilized liposomes. Lu J; Jeon E; Lee BS; Onyuksel H; Wang ZJ J Control Release; 2006 Feb; 110(3):505-13. PubMed ID: 16356575 [TBL] [Abstract][Full Text] [Related]
2. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models. Zhang J; Jin W; Wang X; Wang J; Zhang X; Zhang Q Mol Pharm; 2010 Aug; 7(4):1159-68. PubMed ID: 20524673 [TBL] [Abstract][Full Text] [Related]
3. VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery. Dagar S; Sekosan M; Lee BS; Rubinstein I; Onyüksel H J Control Release; 2001 Jul; 74(1-3):129-34. PubMed ID: 11489489 [TBL] [Abstract][Full Text] [Related]
4. Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo. Li H; Yuan D; Sun M; Ping Q Drug Deliv; 2016 Nov; 23(9):3562-3572. PubMed ID: 27432585 [TBL] [Abstract][Full Text] [Related]
5. Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors. Sinha B; Cao Z; Murray TF; Aldrich JV J Med Chem; 2009 Dec; 52(23):7372-5. PubMed ID: 19621878 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors. Giakomidi D; Bird MF; McDonald J; Marzola E; Guerrini R; Chanoch S; Sabu N; Horley B; Calo G; Lambert DG PLoS One; 2021; 16(4):e0250011. PubMed ID: 33891604 [TBL] [Abstract][Full Text] [Related]
7. Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells. Terada T; Mizobata M; Kawakami S; Yabe Y; Yamashita F; Hashida M J Drug Target; 2006 Sep; 14(8):536-45. PubMed ID: 17050120 [TBL] [Abstract][Full Text] [Related]
8. Disaccharide-modified liposomes and their in vitro intracellular uptake. Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539 [TBL] [Abstract][Full Text] [Related]
9. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4. Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253 [TBL] [Abstract][Full Text] [Related]
10. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q J Control Release; 2005 Oct; 107(2):262-75. PubMed ID: 16125816 [TBL] [Abstract][Full Text] [Related]
11. [Study on the hepatocytic cell targetability of liposomes]. Hou XP; Wang L; Wang XT; Li S Yao Xue Xue Bao; 2003 Feb; 38(2):143-6. PubMed ID: 12778752 [TBL] [Abstract][Full Text] [Related]
12. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo. Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma. Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248 [TBL] [Abstract][Full Text] [Related]
14. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells. Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764 [TBL] [Abstract][Full Text] [Related]
15. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells. Li Q; Yan Z; Li F; Lu W; Wang J; Guo C Nanotechnology; 2012 Jul; 23(26):265101. PubMed ID: 22700686 [TBL] [Abstract][Full Text] [Related]
16. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats. Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772 [TBL] [Abstract][Full Text] [Related]
17. Delivery of cytokines by liposomes. I. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes. Kedar E; Rutkowski Y; Braun E; Emanuel N; Barenholz Y J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):47-59. PubMed ID: 8081559 [TBL] [Abstract][Full Text] [Related]
18. Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomes. Tyagi N; Ghosh PC Eur J Pharm Sci; 2011 Jul; 43(4):343-53. PubMed ID: 21621613 [TBL] [Abstract][Full Text] [Related]